Problem-Decidual macrophages (dMϕ) of the mother and placental macrophages (Hofbauer cells, HC) of the fetus are deployed at a critical location: the feto-maternal interface. This study was conducted to compare DNA methylome of maternal and fetal monocytes, dMϕ, and HC, and thereby to determine the immunobiological importance of DNA methylation in pregnancy.
Introduction
Macrophages play key roles in immune responses against a wide variety of insults such as infection [1] [2] [3] and allograft rejection. 4, 5 Human pregnancy is considered an immunologic enigma since the semi-allogeneic fetal graft is accepted and tolerated during the course of pregnancy. [6] [7] [8] The mechanisms proposed for immunological tolerance to the fetus include the expression of non-classical HLA molecules on trophoblasts, 9, 10 changes in tryptophan metabolism by indoleamine 2,3-dioxygenase, 11, 12 and regulatory T cells. [13] [14] [15] [16] [17] [18] [19] [20] [21] Placental development, ranging from trophoblast invasion to deportation of trophoblast debris into intervillous maternal circulation, is associated with the changes in the frames of fetomaternal immune interaction. [22] [23] [24] [25] [26] [27] Therefore, the human placenta is at the epicenter of the feto-maternal interface, and maternal cells of the decidua interact direct with fetal cells, typically trophoblasts, beginning at the time of implantation and continuing throughout pregnancy. 15, [28] [29] [30] [31] Maternal decidual macrophages (dMϕ) and fetal placental macrophages (Hofbauer cells, HC), are important cell populations at the feto-maternal interface. [32] [33] [34] [35] [36] [37] [38] [39] They interact continuously with potential immunological signals (microbial or danger signals) 40, 41 and cells from the fetus and the mother. [42] [43] [44] [45] [46] [47] [48] [49] These two types of macrophages (dMϕ and HC) are known to originate from maternal and fetal blood monocytes although chorionic mesenchymal cells have been proposed as a major source of HC before the formation of villous stromal capillaries. 50, 51 Changes in the immunophenotype, metabolic characteristics, and distribution of peripheral monocytes and dMϕ have been implicated in the pathogenesis of pregnancy disorders such as preeclampsia, [52] [53] [54] [55] [56] preterm labor with intact membranes, 57 preterm premature rupture of membranes, 58 fetal systemic inflammation, 2, 59-61 and pyelonephritis. 62 HC have been implicated in the pathogenesis of pregnancy complications 63 and they are activated in the presence of placental lesions consistent with maternal anti-fetal cellular rejection. 64, 65 DNA methylation is a prototypic example of epigenetic regulation of gene expressions along with small non-coding RNA and histone tail modifications. [66] [67] [68] [69] DNA methylation largely involves the cytosine residues of CpG dinucleotides in mammalian cells, and hypermethylation leads to the decreased expression of the genes as seen in several tumor suppressor genes during carcinogenesis. 70, 71 DNA methylation is mediated by a family of DNA methyltransferases (DNMT1, DNMT3A, DNMT3B), 72, 73 and is important in various cellular processes such as differentiation, 74 transcription of genes, 75 and genomic imprinting. 76 Recent studies have demonstrated associations between placental DNA methylation patterns and pregnancy disorders. An analysis of 1,505 CpG sites revealed hypomethylation of 34 loci including the promoter region of TIMP3 in early-onset preeclampsia cases compared to control subjects. 77 It was also shown that hypomethylation of the H19 promoter region is associated with increased H19 expression in the placentas of fetal growth restriction cases. 78 However, considering the heterogeneity of placental cell types and cell type specificity of DNA methylation patterns, 79 the procurement of specific cell populations would be important in the comparative analysis of DNA methylation patterns in the placenta.
DNA methylation has been shown to be important in the differentiation of hematopoietic progenitor cells, and a subset of genes involved in differentiation is hypomethylated in monocytes and granulocytes during hematopoiesis. 80 Ji et al also have described drastic alterations of DNA methylation with lymphoid and myeloid restriction from their progenitor cells during hematopoiesis. 81 These findings indicate that the changes in CpG methylation are very important in lineage-specific hematopoietic cell differentiation. Tissue macrophages are mainly derived from peripheral blood monocytes to meet the local needs. 82 We hypothesized that distinct changes in DNA methylation occur during differentiation of maternal monocytes (MMo) into dMϕ and during differentiation of fetal monocytes (FMo) into HC, and differential DNA methylation patterns will give clues for further understanding of the immunological characteristics of these cells during human pregnancy.
In the present study, we have compared the DNA methylome of MMo, FMo, dMϕ, and HC using paired sets of samples and thereby to determine the immunobiological importance of DNA methylation in normal pregnancy.
Materials and Methods

Study Design
The study was designed to compare the DNA methylome of MMo, FMo, dMϕ, and HC. The paired samples were obtained from normal pregnant women at term not in labor and their own babies (n=26) enrolled to the bank of biological materials of the Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, USA. Peripheral blood of mothers was collected by venipuncture when admitted for cesarean section, and fetal cord blood was collected from the umbilical vein during cesarean section. The placentas were used to obtain decidual and villous macrophages. The numbers of paired samples used in the different experiments are as follows: Infinium methylation assay (n=6), pyrosequencing (n=6), quantitative RT-PCR (n=5), immunoblotting (n=4), dMϕ culture with 5-azacytidine treatment (n=5), and BrdU assay (n=4). Samples isolated by flow sorting were used for Infinium methylation assay and pyrosequencing, which require more pure cell populations. Faster cell column isolation was used for quantitative RT-PCR, immunoblotting, and cell culture in order to obtain more fresh samples in spite of relatively lower purity. Participating women provided written informed consent, and the collection and use of the samples and clinical data for research purposes were approved by the Institutional Review Boards of Wayne State University and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services.
Isolation of blood monocytes by flow cytometric cell sorting
Peripheral blood mononuclear cells (PBMCs) were isolated from maternal and fetal cord blood in EDTA by discontinuous density gradient centrifugation using Histopaque 1077 (Sigma-Aldrich, St. Louis, MO, USA). PBMCs were stained with phycoerythrin (PE)-Cy7-conjugated anti-CD14, and allophycocyanin (APC)-conjugated anti-CD15 (BD Biosciences, San Jose, CA, USA; for each). CD14+CD15-monocytes were sorted using a FACS Aria ™ Cell Sorter (BD Biosciences), while CD14dim+CD15+ neutrophils and the other unstained cells were negatively selected.
Isolation of tissue macrophages by flow cytometric sorting
For isolation of dMϕ, decidual tissue (7 gm), procured by scraping the decidual side of the chorion and followed by mincing with a razor blade, was incubated in 50 ml of RPMI 1640 (Invitrogen, Carlsbad, CA, USA) containing 10% FBS and Dispase (2 mg/ml; Invitrogen) at 37 °C for 30 min with shaking (175 rpm). Then the samples were centrifuged at 600 × g for 5 min, and the pellets were resuspended and incubated in 50 ml of RPMI 1640 containing type IV collagenase (2 mg/ml; Worthington Biochemical Corporation, Lakewood, NJ, USA), hyaluronidase (2 mg/ml; Sigma-Aldrich), and DNase I (50 μg/ml; Roche, Mannheim, Germany) for 30 min at 37°C with shaking. The digest was homogenized using a syringe with a 20-gauge needle, and incubated for an additional 30 min at 37°C with shaking (175 rpm). After filtering through the gauze and 100-micron nylon mesh, the digests were washed 2 times with DPBS and the cell numbers were counted. Antibody labeling and cell sorting were performed as described above for blood monocytes.
For isolation of HC, the basal plate, the chorionic plate, and grossly visible blood vessels were removed from the placental tissue. After 3 washes with DPBS, 7 gm of villous tissues were used for a four-stage digestion protocol to isolate single cells from villous tissue. 83 First, 50 ml of collagenase type 1A (0.624 mg/ml; Sigma-Aldrich) solution containing 0.684 mg/ml of hyaluronidase (Sigma-Aldrich), 0.12 mg/ml of DNase I (Roche), and 1 mg/ml of BSA (Sigma-Aldrich) in DPBS was added to the tissue. Following incubation for 6 min at 37°C with shaking (175 rpm), the tubes were kept on ice for 5 min and supernatant was discarded. For the second stage, 50 ml of trypsin solution (0.25 %, Invitrogen) containing 0.12 mg/ml of DNase I (Roche) and 0.5 mM of EDTA (pH 8.0, Invitrogen) were added and incubated at 37°C for 30 min with shaking (175 rpm). The tissue digest was centrifuged at 600×g for 5 min, and the pellet was then incubated with collagenase type IV (2 mg/ml; Worthington) in 50 ml of RPMI 1640 (10% FBS without antibiotics) containing 2 mg/ml of hyaluronidase (Sigma-Aldrich), and 50 μg/ml of DNase I (Roche) at 37°C for 30 min with shaking (175 rpm). The tissue digest was centrifuged at 600×g for 5 min and the supernatant was removed. Finally, collagenase type IV treatment was repeated. Following the digestion process, tissue digest was homogenized using a syringe with a 20-gauge needle, and incubated for an additional 30 min at 37°C with shaking. This digest was filtered and washed according to the same procedure used for decidual cell isolation as described above. Antibody labeling and cell sorting were performed as described above for blood monocytes.
Monocyte and macrophage isolation using a separation column
Monocytes and macrophages were isolated using cell separation columns. PBMCs of maternal blood and fetal cord blood were isolated by discontinuous density gradient centrifugation using Histopaque 1077 (Sigma-Aldrich). After lysing the red blood cells with sterile 0.2 % NaCl (pH 6.75) for 45 s, the cells were restored with sterile 1.6 % NaCl (pH 6.75) and centrifuged at 300 ×g for 5 min. Monocytes were isolated using Monocyte Isolation Kit II and MS columns (Miltenyi Biotech Inc., Auburn, CA, USA) according to the manufacturer's instructions. A small fraction of isolated monocytes were stained with APCconjugated CD14 for the flow cytometric assessment of purity.
For isolation of dMϕ and HC, isolated single cells obtained by the protocols described above were incubated with sterile 0.2 % NaCl (pH 6.75) for 45 s and restored with sterile 1.6 % of NaCl (pH 6.75). Following removal of dead cells using a Dead Cell Removal Kit (Miltenyi Biotech), macrophages were isolated by CD14 microbeads and LS columns (Miltenyi Biotech). A small fraction of isolated macrophages were stained with APC-conjugated CD14 for flow cytometry.
Confirmation of isolated monocytes and macrophages
Each population of positively sorted cells was reanalyzed by flow cytometry to evaluate the purities of monocytes and macrophages. For visualization of the sorted CD14+ monocytes and macrophages in a few representative cases, positively selected PE-Cy7-conjugated anti-CD14+ cells were smeared on silanized slides, and mounted with Prolong Gold Antifade Reagent with DAPI (Invitrogen). The cells were examined using a Leica TCS SP5 spectral confocal system (Leica Microsystems, Wetzler, Germany).
Infinium methylation assay
Genomic DNA of sorted MMo, FMo, dMϕ, and HC from women at term not in labor (n=6) was isolated using a QIAamp DNA FFPE Tissue Kit (Qiagen, Valencia, CA, USA). DNA (500 ng) samples were bisulfite modified using an EZ DNA Methylation Kit (Zymo Research, Irvine, CA, USA), and were hybridized with the Illumina Human Methylation27 BeadChip (Illumina, Inc., San Diego, CA, USA), according to the manufacturer's instructions. After hybridization, allele-specific single-base extension and x-staining were performed on the BeadChip, and fluorescent signals were acquired with the Bead Array Reader (Illumina). The data from these images were analyzed using BeadStudio Methylation Module (Illumina), and the relative level of methylation (β) was calculated as the ratio of methylated-locus signal to total locus signal intensity.
Bioinformatics analysis
The relative level of methylation (β value) ranges between 0 and 1 with values close to 0 indicating no methylation and values close to 1 indicating presence of methylation. The raw data was quantile normalized 84 among the 24 samples and differential methylation was tested using a paired moderated t-test. 85 A given locus was deemed significant if its False Discovery Rate 86 adjusted p-value (called q-value) was less than 0.05 and the difference in average β values between the two groups was 0.2 β units or more. Differentially methylated gene listswere interpreted using Gene Ontology (GO) terms explaining that they enrich using an over-representation analysis 87 implemented in the Bioconductor (www.bioconductor.org) package GOStats. 88 All analyses were performed using the R statistical language (www.r-project.org).
Bisulfite DNA pyrosequencing
Based on the results obtained from the Infinium Methylation Assay, the methylation status of LAG3, INCA1, and IL1B promoter regions was validated by bisulfite pyrosequencing. Genomic DNA (500 ng) samples of MMo, FMo, dMϕ, and HC from an independent group of pregnant women at term not in labor (n=6) were treated with bisulfite, and the samples were purified using Zymogen DNA columns (Zymo Research). Bisulfite-treated DNA was eluted in 20 μl of TE buffer (pH 8.0), and 1 μl was used for each PCR. PCR was performed with 0.2 μM of forward and reverse primers, and the PCR product was immobilized to Streptavidin Sepharose HP (Amersham Biosciences, Uppsala, Sweden). The Sepharose beads containing the immobilized PCR product were purified, washed and denatured using a 0.2 M NaOH solution and rewashed using the Pyrosequencing Vacuum Prep Tool (Qiagen), according to the manufacturer's instructions. For pyrosequencing, 0.2 μM of sequencing primers was annealed to the purified single-stranded DNA, and 10 μl of the PCR products were sequenced by Pyrosequencing PSQ96 HS System (Biotage AB, Uppsala, Sweden), according to the manufacturer's instructions. The methylation status of each locus was analyzed individually as a T/C SNP using QCpG software (Qiagen).
Real-time quantitative RT-PCR
The total RNA of monocytes and macrophages (n=5) was isolated using the RNeasy Mini Kit (Qiagen). Reverse transcription was done using the ImpromII Reverse Transcription System (Promega, Madison, WI, USA). All PCR analyses were carried out using TaqMan assays (Applied Biosystems, Foster City, CA, USA) for DNMT1 (Hs00154749_m1), DNMT3A (Hs01027166_m1), DNMT3B (Hs00171876_m1), INCA1 (Hs01652223_m1), and RPLPO (4326314E). PCR reactions were done using the 7500 Fast Real-Time PCR System (Applied Biosystems).
Immunoblotting
Total proteins from monocytes and macrophages (n=4) were isolated using RIPA buffer (Sigma-Aldrich) containing a protease inhibitor cocktail (Roche). Twenty μg of proteins were subjected to 10 % SDS-polyacrylamide gel electrophoresis, and electro-transferred onto nitrocellulose membranes. The membranes were blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20, and probed overnight at 4°C with a rabbit polyclonal anti-INCA1 (1:500 dilution; ProSci Inc, Poway, CA, USA) or a mouse monoclonal anti-β-actin (1:5,000 dilution; Sigma-Aldrich). Horseradish peroxidaseconjugated anti-rabbit or mouse IgG (Vector Laboratories, Burlingame, CA, USA) was used as a secondary antibody, and signals were detected by chemiluminescence using ChemiGlow West Reagents (Alpha Innotech Corporation, San Leandro, CA, USA).
Decidual macrophage culture with 5-Azacytidine treatment and BrdU incorporation assay
The dMϕ (n=5) were plated in 6-well plates at the density of 5 × 10 5 cells per well in RPMI1640 (Invitrogen) media supplemented with 10 % FBS and antibiotics. The cells were treated with 5-azacytidine (Sigma-Aldrich) at the concentration of 5, 10, or 50 μM for 3 days. The cells were then pulsed with BrdU (10 μM) for 1 h, and stained using a BrdU Flow Kit (BD Bioscience), according to the manufacturer's instructions. Briefly, the cells were fixed and permeabilized with BD Cytofix/Cytoperm buffer, and incubated with BD Cytoperm Plus buffer. The cells were then fixed again with BD Cytofix/Cytoperm Buffer, followed by DNase (0.3 mg/ml) treatment for 1 h at 37°C. After staining with FITCconjugated anti-BrdU antibody, the cells were analyzed for BrdU uptake using BD LSR II flow cytometry (BD Biosciences) equipped with BD FACSDiva software version 6.0. Total events numbered 3,000.
Statistical analysis
Wilcoxon signed rank tests for related variables and the Mann-Whitney U test for independent variables were performed using the SPSS version 15.0 (SPSS Inc, Chicago, IL, USA). All p-values were two-sided, and a value of p<0.05 was considered to be statistically significant.
Results
Purity of isolated monocytes and macrophages
The purity of monocytes and macrophages isolated by cell sorter for microarray and pyrosequencing was higher than 60.0% in all samples analyzed (Figure 1 ). (Figure 3 ). The data set is available in www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=tlyrpmsaqwkqwpe&acc=GSE31680.
In the comparisons between the mother and the fetus, 65 loci were differentially methylated between MMo and FMo, whereas 266 loci were differentially methylated between dMϕ and HC. Among the 65 differentially methylated loci, 25 loci and 40 loci were hyper-and hypomethylated in MMo compared to FMo. Interestingly, most of the immune response-related genes such as SP2, LAG3, PGLYRP2, GBP1, and CX3CL1 were hypermethylated in FMo. When the methylation patterns of dMϕ and HC were compared, 145 loci were hypermethylated in dMϕ and 121 loci were hypermethylated in HC. Many of the immune response-related genes such as EDG6, ADA, PGLYRP1, CST7, TRAF1, IL1B, PTGDR, LAG3, and CD79A were found to be hypermethylated in HC. Other differentially methylated loci included the genes related to cell cycle and apoptosis such as INCA1, CASP8, and AIM2 (Table I) . Of note, INCA1 and LAG3 were also among those 15 loci whose differential methylation was found both in the comparisons between MMo and FMo and between dMϕ and HC (Table II) .
DNA methylation patterns: maternal monocytes vs. decidual macrophages and fetal monocytes vs. Hofbauer cells
In the comparisons between blood monocytes and tissue macrophages, 199 loci were differentially methylated between MMo and dMϕ, and 1,030 loci were differentially methylated between FMo and HC (Table I) . Of note, the majority [160/199 (80%)] of the differentially methylated loci between MMo and dMϕ were also differentially methylated between FMo and HC (Table II) .
Gene Ontology analysis of differentially methylated genes revealed enrichment of 215 biological processes for MMo vs. dMϕ comparison and 52 processes for FMo vs. HC (Table  III) . Most of the biological processes enriched in comparison between FMo vs. HC (51/52) were also enriched in comparison between MMo and dMϕ, and they were related to the variable aspects of immune responses, complement activation, cell adhesion, and angiogenesis. The biological processes enriched in the comparison between MMo and dMϕ included ion homeostasis, coagulation, and aminoglycan metabolic processes.
In the comparison between MMo vs. dMϕ, the genes encoding markers of classical macrophage activation such as TLR9, IL1B, IL12RB2, CD48, and FGR were hypermethylated in dMϕ, while those of alternative macrophage activation markers such as CCL13, CCL14, A2M, HNMT, and IL10 were hypomethylated. The results suggested that the anti-inflammatory property of human dMϕ is partly associated with its DNA methylation pattern. The comparison of FMo vs. HC also demonstrated hypermethylation of the genes encoding markers of classical macrophage activation such as TLR9, IL1B, IL12RB2, CD48, and FGR in HC, whereas the genes encoding alternative macrophage activation markers such as CCL2, CCL13, CCL14, CD209, and A2M were hypomethylated in HC.
Of note, two key enzymes, DNMT1 and DNMT3B, involved in DNA methylation were also among the differentially methylated loci between FMo and HC.
Confirmation of CpG methylation of specific genes: LAG3, INCA1, IL1B
Three genes (LAG3, INCA1, IL1B) were selected for further validation of the methylation status in each type of cells. LAG3 and INCA1 were differentially methylated between maternal and fetal cells (MMo vs. FMo and dMϕ vs HC; Table IIA), and IL1B was found to be differentially methylated between the blood monocyte and the tissue macrophage both in the mother and the fetus (Table IIB) . Three CpG sites of each gene for bisulfite pyrosequencing were chosen from the region interrogated by methylation microarray, and the sequencing results of the three genes correlated with the microarray data. As shown in Figure 4A , the methylation percentages of the LAG gene in MMo and dMϕ were lower than those in FMo and HC, respectively (p<0.05 for each). The median of methylation percentages was 59.5% for MMo, 82.8% for FMo, 60.2% for dMϕ, and 82.0% for HC. The degree of methylation across three CpG sites of the INCA1 promoter region was also confirmed to be higher in MMo (61.3%) than in FMo (45.3%), and in dMϕ (35.1%) than in HC (8.7%), respectively (p<0.05 for each, Figure 4B ). For IL1B, which was found to be differentially methylated between monocyte and macrophage in the microarray analysis, the median of methylation percentages was 31.1% for MMo, 51.9 % for dMϕ, 30.4% for FMo, and 69.4% for HC, also confirming the microarray data ( Figure 4C ).
DNMT expression in blood monocytes, decidua, and chorionic villi
As DNMT1 and DNMT3B were among the differentially methylated loci between FMo and HC in the microarray analysis and as they are major methyltransferases, we evaluated mRNA expression levels of DNA methyltransferases (DNMT), DNMT1, DNMT3A, and DNMT3B by quantitative RT-PCR using RNA samples from MMo, FMo, dMϕ, and HC. mRNA expressions of DNMT1, DNMT3A, and DNMT3B were significantly lower in dMϕ when compared to MMo and HC. DNMT1 mRNA expression in MMo was higher than that of FMo (p<0.05 for each, Figure 5 ). The data suggested that the differences in the methylation patterns of the cells tested are partly associated with the expression of DNMTs.
Increased expression of INCA1 mRNAby 5-azacytidine
Based on the microarray and pyrosequencing data, we further studied the effects of 5-azacytidine induced demethylation on the mRNA expression of INCA1 (inhibitor of CDK interacting with cyclin A1). INCA1 was hypermethylated in MMo or dMϕ and hypomethylated in FMo or HC. Quantitative RT-PCR and immunoblotting were used to confirm expression levels of INCA1 in monocytes and macrophages. INCA1 mRNA expression was significantly down-regulated in dMϕ compared to HC (p<0.05); however, there was no significant difference between MMo and FMo ( Figure 6A ). This seemed to be due to a relatively small difference in the extent of DNA methylation between MMo and FMo. INCA1 protein expression was also significantly lower in dMϕ than in HC as well as in MMo than FMo ( Figure 6B ).
The treatment of isolated dMϕ with 5-azacytidine (10 nM) for 3 days significantly increased INCA1 mRNA expression by 3.1 fold (p<0.05, Figure 6C ). Because INCA1 is an inhibitor of cell cycle progression, 89, 90 we further studied the effect of the INCA1 methylation on the proliferation of macrophages by BrdU labeling. Following the treatment with 5-azacytidine for 3 days, the dMϕ were pulsed with BrdU. Flow cytometric evaluation demonstrated decreased BrdU labeling in dMϕ with 5-azacytidine treatment in a dose-dependent manner (p<0.05, Figure 6D ).
Discussion
Monocytes and macrophages are important in the immunological interaction between the mother and the fetus. 91, 92 We investigated the methylome of blood monocytes and tissue macrophages at the feto-maternal interface. The principal findings of this study are: 1) There are distinct differences in the DNA methylation patterns between maternal cells and fetal cells (MMo vs. FMo; dMϕ vs. HC), and the majority of differentially methylated genes related to immune response are hypermethylated in the fetal cells; 2) The methylation patterns of monocytes and macrophages are also quite different (MMo vs. dMϕ; FMo vs. HC), and the differential methylation pattern is more prominent between FMo and HC; 3) Gene Ontology analysis of differentially methylated genes demonstrates significant enrichment of many biological processes associated with immune responses in monocyte vs. macrophage comparisons; 4) Pyrosequencing confirmed microarray results of three genes tested (LAG3, INCA1, IL1B); 5) mRNA expression of DNMT1, DNMT3A, and DNMT3B was significantly lower in dMϕ compared to HC; and 6) Treatment of dMϕ with 5-azacytidine significantly increased mRNA expression of INCA1 with a concomitant decrease in BrdU labeling.
DNA hypermethylation in fetal monocytes relevant to their impaired immune responses
Hypermethylation of the genes related to immune response in FMo compared to MMo indicates that DNA methylation contributes to decreased immune response capacity of FMo compared to MMo. The results are quite consistent with the gene expression data in a recent transcriptome study of adult peripheral monocytes and umbilical cord blood monocytes. Jiang et al have shown differential increases in gene expression between adult monocytes and cord blood monocytes activated by lipopolysaccharides including cytokines, chemokines, transcription factors, signal transduction, apoptotic regulation, and cell structure. 93 A previous study on relatively impaired responses of neonatal monocytes and macrophages to multiple Toll-like receptor ligands also supports immature functional capacity of neonatal monocytes compared to that of adult monocytes. 94 An additional possible explanation for differential methylation between FMo and MMo may be age-related DNA methylation changes. 95 The CD34+ hematopoietic progenitor cells from adult peripheral blood showed differential methylation patterns compared to those from cord blood 80 and age-related DNA methylation changes are tissue-specific. 95 
DNA methylation during monocyte-macrophage differentiation
The present study clearly demonstrates distinct changes of DNA methylation during monocyte-macrophage differentiation. The differences are more profound between FMo and HC. The dMϕ and HC are deployed at the immunologically sensitive location: the fetomaternal interface where an enhanced pro-inflammatory response can be detrimental to the maintenance of pregnancy. Therefore, hypermethylation of certain genes encoding classical activation markers and hypomethylation of a subset of gene-encoding alternative activation markers of macrophages in dMϕ compared to MMo and in HC compared to FMo are biologically quite relevant. DNA methylation seems to contribute to the anti-inflammatory phenotype of dMϕ and HC. Gustafsson et al compared the transcriptome of CD14+ macrophages isolated from first trimester decidual tissue and peripheral blood monocytes. Their study also has shown that the expression of the genes encoding alternative macrophage activation markers such as CCL18 and CD209 is higher in dMϕ. Therefore, dMϕ displays an anti-inflammatory phenotype compared to maternal blood monocytes. 96 Of note, their observation of increased expression of alpha-2-macroglobulin (A2M) in dMϕ is consistent with the hypomethylation of this gene in this study, whereas decreased expressions of asialoglycoprotein receptor 2 (ASGR2) and intercellular adhesion molecule 3 (ICAM3) are relevant with the hypermethylation of these genes in dMϕ. In addition to the differential methylation of CpG sites, the M2-macrophage phenotype is epigenetically regulated by chromatin remodeling following reciprocal changes in histone H3 lysine-4 and histone H3 lysine-27 methylation. 97 Our data is also consistent with recent observations on the expression of selected molecules associated with macrophage polarization in HC. 98, 99 Studies have shown that M2 markers such as DC-SIGN, CD163, and mannose receptor/ CD206 are detectable in HC but not in M1 markers (CX3CR1, IL7R, CCR7). Expression of different combinations of M2 markers in dMϕ and HC which do not precisely match the transcriptional profile of in vitro generated M2 macrophages also suggests the potential importance of the tissue microenvironment during monocyte to macrophage differentiation. 100, 101 A more profound difference in the DNA methylome between FMo and HC than between MMo and dMϕ has biological implications. The origin of placental HC has been controversial. It has been proposed that they derive from chorionic mesenchymal cells in the villous stroma before the formation of villous capillaries, 50, 51 while mobilization of blood monocytes becomes the main route after the development of capillaries 102 Therefore, HC might represent a heterogeneous population of cells in the context of histogenesis. Our observation of transdifferentiation of myofibroblasts into macrophages in the chorionic mesoderm of the reflected chorion also supports that HC can differentiate from chorionic mesenchymal cells. 103 Furthermore, HC can normally proliferate, or in response to biological stimuli such as inflammation 64, 104 and pro-inflammatory cytokines such as IL-6, would confer more chances of DNA methylation by changing gene expression patterns and increasing expression of methyltransferase. 105 Hypomethylation of INCA1 in HC compared to dMϕ may also in turn contribute to the difference in the proliferative potential of these fetal and maternal cells.
Differential regulation of DNA methyltransferase expression
This study also reports an interesting feature of the regulation of DNA methyl transferase expression. DNMT1 and DNMT3B were among differentially methylated loci between FMo and HC, and their mRNA expressions in dMϕ were lower than those in MMo and HC, which in turn could modify overall methylation patterns of the cells studied. DNMTs have two types of actions. DNMT1 is responsible for the maintenance of DNA methylation status, while DNMT3A and DNMT3B are important for de novo methylation. 72, 73 DNMT1 is expressed ubiquitously whereas DNMT3A and DNMT3B have tissue-specific expression patterns. 106 Promoter methylation of DNA methyltransferases themselves may have a broader impact on methylation patterns, and hypomethylation of DNMT3B was demonstrated in glial tumors. 107 We also demonstrated that differential DNA methylation patterns have biological significance by showing the effects of INCA1 in dMϕ.
Limitations of this study
There are limitations to this study. First, the samples used for the analysis in the present study were obtained from normal pregnant women at term, and the data related to pathologic pregnancies are not available. Intra-amniotic infection by microbial invasion of the amniotic cavity is a leading cause of preterm birth [108] [109] [110] [111] and elicits a robust acute inflammatory response of the fetus. 2, 60, 61, [112] [113] [114] [115] [116] [117] [118] [119] [120] Furthermore, the process is associated with an elevation of the amniotic fluid concentrations of cytokines and chemokines such as macrophage migration inhibitory factor and monocyte chemotactic protein-1. 2, [121] [122] [123] The fetal chorionic mesenchymal cells also acquire macrophage phenotype in the presence of intraamniotic infection and chorioamnionitis. 103 Therefore, the biological significance of DNA methylation of fetal and maternal monocytes and macrophages during intra-amniotic infection needs to be further studied. The data also might not represent the methylome of dMϕ or HC in the early gestational period. It is well-known that the number of HC decreases with advancing gestation. 124 Considering the duration of gestation, it is very likely that methylation patterns of macrophages change across gestation. Houser et al have recently demonstrated that there are two different populations of CD14+ macrophages according to the expression level of CD11c (high vs. low) in the first trimester decidual tissues with different functional implications in lipid metabolism, inflammation, and tissue growth. 125 Therefore, it is possible that different subpopulations of macrophages were analyzed together in our analysis.
Conclusions
We report the DNA methylome of maternal and fetal monocytes and macrophages at the feto-maternal interface for the first time. The distinct nature of DNA methylation patterns in each subset of cells strongly suggests that epigenetic regulation of multiple genes is at the core of functional diversification of the critical players in maternal and fetal immune interaction during pregnancy. Particularly, DNA methylation seems to be a part of the machinery conferring an anti-inflammatory phenotype to the macrophages at the fetomaternal interface. Venn diagram summary of differentially methylated loci between the groups. Differentially methylated loci were using a FDR cut-off of 5% and average DNA methylation difference (Δβ)>0. 
